NUP98::NSD1 and FLT3/ITD co-expression is an independent predictor of poor prognosis in pediatric AML patients

[1]  Serena Tseng,et al.  A Review of Childhood Acute Myeloid Leukemia: Diagnosis and Novel Treatment , 2023, Pharmaceuticals.

[2]  S. Raimondi,et al.  Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia , 2023, Haematologica.

[3]  J. Klco,et al.  Mechanistic insights and potential therapeutic targets for NUP98-rearranged hematologic malignancies. , 2020, Blood.

[4]  P. Aplan,et al.  Clinical and molecular consequences of fusion genes in myeloid malignancies , 2020, Stem cells.

[5]  D. Reinhardt,et al.  Mutated WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia , 2019, Journal of oncology.

[6]  Y. Hayashi,et al.  Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML‐05 study , 2019, British journal of haematology.

[7]  M. Patnaik.  The importance of FLT3 mutational analysis in acute myeloid leukemia , 2018, Leukemia & lymphoma.

[8]  A. Baruchel,et al.  Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group , 2018, HemaSphere.

[9]  Hamid Bolouri,et al.  The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions , 2017, Nature Medicine.

[10]  G. Leverger,et al.  NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis , 2017, Leukemia.

[11]  Bob Löwenberg,et al.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.

[12]  C. Zwaan,et al.  Pediatric AML: From Biology to Clinical Management , 2015, Journal of clinical medicine.

[13]  L. Bullinger,et al.  Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation. , 2014, Blood.

[14]  S. Raimondi,et al.  NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report. , 2014, Blood.

[15]  S. Raimondi,et al.  Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  S. Akiki,et al.  NUP98‐NSD1 fusion in association with FLT3‐ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR , 2013, Genes, chromosomes & cancer.

[17]  Y. Hayashi,et al.  NUP98‐NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia , 2013, Genes, chromosomes & cancer.

[18]  P. Aplan,et al.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. , 2011, Blood.

[19]  R. Rosenquist,et al.  Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia. , 2011, Blood.

[20]  R. Pieters,et al.  NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. , 2011, Blood.

[21]  N. Tosic,et al.  Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review. , 2009, Cancer genetics and cytogenetics.

[22]  Y. Hayashi,et al.  Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: A study of the Japanese childhood AML Cooperative Study Group , 2008, Pediatric blood & cancer.

[23]  J. Radich,et al.  FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. , 2003, Blood.

[24]  J. Cheng,et al.  A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia. , 2001, Blood.

[25]  I. Bernstein,et al.  Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. , 2001, Blood.